Critical Care Management of COVID-19

<p>Critical Care Management of COVID-19</p> <p>Special Guests: Drayton Hammond, PharmD, MBA, MSc, BCPS, BCCCP, FCCM</p> <p>Peter Nikolos, PharmD</p> <p> </p> <p>Show Notes: https://pharmacytodose.files.wordpress.com/2020/04/covid-19-complications-show-notes.pdf</p> <p> </p> <p>Mechanical Ventilation (Drayton)</p> <p>08:00 – Non-COVID-19 PAD management; 11:16 – COVID-19 PAD management; 18:22 – Managing PAD drug shortages; 22:38 – Opioid conservation strategies; 26:08 – Propofol conservation strategies; 29:08 – Hypertriglyceridemia with propofol; 32:10 – Risk of PRIS; 34:30 – Ketamine; 41:05 – NMBA use and shortage; 46:00 – PPE conservation; 49:00 – Bronchodilator use for COVID-19; 50:28 – Inhaled anticoagulants; 52:46 – Inhaled pulmonary vasodilators; 54:17 – Advice for COVID-19 management</p> <p> </p> <p>Cardiovascular (Peter)</p> <p>67:20 – Current shortages; 71:05 – First-line vasopressor; 73:25 – Vasopressor compounding and utilization changes; 74:50 – Smart pump management; 77:15 – Vasopressor shortage management; 79:45 – Anticoagulation treatment strategy; 85:30 – Anticoagulation monitoring; 86:28 – Anticoagulation in ECMO/CRRT; 88:20 – PE causing rapid decompensation?; 90:25 – Alternate anticoagulants; 92:52 – Thrombolytics in ACS; 98:13 – Code response changes; 100:05 – ACE-I/ARB use in COVID-19; 103:41 – NSAID use in COVID-19; 105:15 – Statin use in COVID-19; 107:25 – Challenges from virtual rounding; 110:20 – Key points on COVID-19 management</p> <p> </p> <p>PharmacyToDose.Com</p> <p>@PharmacyToDose on Twitter/Instagram</p> <p><a href='mailto:PharmacyToDose@Gmail.com'>PharmacyToDose@Gmail.com</a></p>